Empacoza plus

Composition:

Each Empacoza plus 10/5 mg tablet contains : Empagliflozin.......................... 10 mg.

linagliptin................................................................... 5 mg

Each Empacoza 25/5 mg tablet contains:

empagliflozin.................................................. 25 mg

Linagliptin.................................................................. 5 mg

Therapeutic Indications:

• Fixed dose combination of empagliflozin and linagliptin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:
• To improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Empacoza Plus does not provide adequate glycaemic control.

• when already being treated with the free combination of empagliflozin and linagliptin

Packaging:

Empacoza plus 10/5 mg Tablets: Box containing 3 blisters of 10 tablets.

Each Empacoza plus 25/5 mg Tablets: Box containing 3 blisters of 10 tablets each.